US Stock MarketDetailed Quotes

PRME Prime Medicine

Watchlist
  • 3.150
  • -0.130-3.96%
Close Jan 8 16:00 ET
413.16MMarket Cap-1.53P/E (TTM)

Prime Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prime Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.250M--
--2024/Q4-- / 5.230M--
--2024/Q30.000 / 7.118M--
--2024/Q20.000 / 1.358M--
--2024/Q1591.000K / 912.500K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.250M--
--2024/Q4-- / 5.230M--
--2024/Q30.000 / 7.118M--
--2024/Q20.000 / 1.358M--
--2024/Q1591.000K / 912.500K--

Unlock Free Earnings Estimates

Prime Medicine Earnings Reports

  • Prime Medicine | 8-K: Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 12, 2024 16:55 ET

  • Prime Medicine | 10-Q: Q3 2024 Earnings Report

    Nov 12, 2024 16:16 ET

  • Prime Medicine | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 08:29 ET

  • Prime Medicine | 8-K: Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates

    Aug 8, 2024 08:14 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Collegium Pharmaceutical
    COLL
    +14.41%
    eBay
    EBAY
    +9.86%
    Halozyme Therapeutics
    HALO
    +5.02%
    SilverCrest Metals
    SILV
    +4.63%
    Workday
    WDAY
    +2.01%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data